Americas 2 p.m. EDT | EMEA 1 p.m. BST | APAC 1 p.m. AEST | India 3:30 p.m. IST
Traditional electronic signature approaches don’t work when Life Sciences companies adopt Agile and DevOps.
Testing regulated applications has long required programmatic process controls with electronic signatures. Now, with the shift to Agile processes and DevOps tools, many organizations are attempting to apply traditionally rigid governance practices within processes and tools architected for a much faster, more flexible paradigm. This is a risky approach.
Join our webinar as a panel of Life Sciences and Agile testing experts explore the top challenges and best practices associated with testing regulated Life Sciences applications in Agile and DevOps processes. We’ll cover: